Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031
Induced Pluripotent Stem Cell (IPSC) Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC) market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Where is the largest and fastest growing market for induced pluripotent stem cell (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cell (iPSC) market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider induced pluripotent stem cell (iPSC) market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the induced pluripotent stem cell (iPSC) market.
Key Trends - Highlights the major trends shaping the global induced pluripotent stem cell (iPSC) market. This section also highlights likely future developments in the market.
Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by derived cell type, by application, and by end-user in the market.
Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations - Includes recommendations for induced pluripotent stem cell (IPSC) providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
1) By Derived Cell Type: Blood Cells; Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others
2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell & Gene Therapy
3) By End-User: Hospitals; Research Laboratories
Companies Mentioned: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific, Inc.; Takara Bio, Inc.; Lonza Group AG; Astellas Pharma Inc.
Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cell (iPSC) indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- 1. Executive Summary
- 2. Table of Contents
- 3. List of Figures
- 4. List of Tables
- 5. Report Structure
- 6. Introduction and Market Characteristics
- 6.1. General Market Definition
- 6.2. Summary
- 6.3. Induced Pluripotent Stem Cell (iPSC) Market Definition and Segmentations
- 6.4. Market Segmentation By Derived Cell Type
- 6.4.1. Blood Cells
- 6.4.2. Hepatocytes
- 6.4.3. Fibroblasts
- 6.4.4. Keratinocytes
- 6.4.5. Amniotic
- 6.4.6. Others
- 6.5. Market Segmentation By Application
- 6.5.1. Academic Research
- 6.5.2. Drug Discovery And Toxicity Studies
- 6.5.3. Regenerative Medicine
- 6.5.4. Gene & Cell Therapy
- 6.6. Market Segmentation By End-User
- 6.6.1. Hospitals
- 6.6.2. Research Laboratories
- 7. Major Market Trends
- 7.1. Use of Pluripotent Stem Cells in treating Parkinson’s Disease (PD)
- 7.2. Strategic Collaborations And Partnerships
- 7.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells
- 7.4. Demand For Induced Pluripotent Stem Cell (iPSC) For Cell Therapy
- 7.5. Investment In Regenerative Medicine Research And Development
- 7.6. Advancements In Technology Transfer And Clinical Translation
- 7.7. Use of Pluripotent Stem Cells in treating Type 1 Diabetes
- 8. Global Market Size And Growth
- 8.1. Market Size
- 8.2. Historic Market Growth, 2016 – 2021, Value ($ Million)
- 8.2.1. Market Drivers 2016 – 2021
- 8.2.2. Market Restraints 2016 – 2021
- 8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 8.3.1. Market Drivers 2021 – 2026
- 8.3.2. Market Restraints 2021 – 2026
- 9. Global Market Segmentation
- 9.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 9.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 9.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 10. Global Market, Regional And Country Analysis
- 10.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 10.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11. Asia-Pacific Market
- 11.1. Summary
- 11.2. Market Overview
- 11.2.1. Region Information
- 11.2.2. Market Information
- 11.2.3. Background Information
- 11.2.4. Government Initiatives
- 11.2.5. Regulations
- 11.2.6. Regulatory Bodies
- 11.2.7. Major Associations
- 11.2.8. Taxes Levied
- 11.2.9. Corporate Tax Structure
- 11.2.10. Investments
- 11.2.11. Major Companies
- 11.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 11.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 11.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.7. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
- 11.8. China Market
- 11.9. Summary
- 11.10. Market Overview
- 11.10.1. Country Information
- 11.10.2. Market Information
- 11.10.3. Background Information
- 11.10.4. Government Initiatives
- 11.10.5. Regulations
- 11.10.6. Regulatory Bodies
- 11.10.7. Major Associations
- 11.10.8. Taxes Levied
- 11.10.9. Corporate Tax Structure
- 11.10.10. Investments
- 11.10.11. Major Companies
- 11.11. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 11.12. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 11.13. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.14. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.15. India Market
- 11.16. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 11.17. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 11.18. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.19. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.20. Japan Market
- 11.21. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 11.22. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 11.23. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.24. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.25. Australia Market
- 11.26. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 11.27. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 11.28. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.29. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.30. Indonesia Market
- 11.31. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 11.32. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.33. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.34. South Korea Market
- 11.35. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 11.36. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 11.37. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.38. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12. Western Europe Market
- 12.1. Summary
- 12.2. Market Overview
- 12.2.1. Region Information
- 12.2.2. Market Information
- 12.2.3. Background Information
- 12.2.4. Government Initiatives
- 12.2.5. Regulations
- 12.2.6. Regulatory bodies
- 12.2.7. Major Associations
- 12.2.8. Taxes Levied
- 12.2.9. Corporate Tax Structure
- 12.2.10. Investments
- 12.2.11. Major Companies
- 12.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 12.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 12.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12.7. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
- 12.8. UK Market
- 12.9. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 12.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 12.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12.12. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12.13. Germany Market
- 12.14. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 12.15. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 12.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12.17. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12.18. France Market
- 12.19. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 12.20. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 12.21. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12.22. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13. Eastern Europe Market
- 13.1. Summary
- 13.2. Market Overview
- 13.2.1. Region Information
- 13.2.2. Market Information
- 13.2.3. Background Information
- 13.2.4. Government Initiatives
- 13.2.5. Regulations
- 13.2.6. Regulatory Bodies
- 13.2.7. Major Associations
- 13.2.8. Taxes levied
- 13.2.9. Corporate tax structure
- 13.2.10. Investments
- 13.2.11. Major Companies
- 13.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.7. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
- 13.8. Russia Market
- 13.9. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.12. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14. North America Market
- 14.1. Summary
- 14.2. Market Overview
- 14.2.1. Region Information
- 14.2.2. Market Information
- 14.2.3. Background Information
- 14.2.4. Government Initiatives
- 14.2.5. Regulations
- 14.2.6. Regulatory Bodies
- 14.2.7. Major Associations
- 14.2.8. Taxes levied
- 14.2.9. Corporate tax structure
- 14.2.10. Investments
- 14.2.11. Major Companies
- 14.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 14.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 14.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.6. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.7. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
- 14.8. USA Market
- 14.9. Summary
- 14.10. Market Overview
- 14.10.1. Country Information
- 14.10.2. Market Information
- 14.10.3. Background Information
- 14.10.4. Government Initiatives
- 14.10.5. Regulations
- 14.10.6. Regulatory Bodies
- 14.10.7. Associations
- 14.10.8. Taxes Levied
- 14.10.9. Corporate Tax Structure
- 14.10.10. Investments
- 14.10.11. Major Companies
- 14.11. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 14.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 14.13. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.14. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 15. South America Market
- 15.1. Summary
- 15.2. Market Overview
- 15.2.1. Region Information
- 15.2.2. Market Information
- 15.2.3. Background Information
- 15.2.4. Government Initiatives
- 15.2.5. Regulations
- 15.2.6. Regulatory Bodies
- 15.2.7. Associations
- 15.2.8. Taxes Levied
- 15.2.9. Corporate Tax Structure
- 15.2.10. Investments
- 15.2.11. Major Companies
- 15.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 15.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 15.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 15.6. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 15.7. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
- 15.8. Brazil Market
- 15.9. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 15.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 15.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 15.12. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 16. Middle East Market
- 16.1. Summary
- 16.2. Market Overview
- 16.2.1. Region Information
- 16.2.2. Market Information
- 16.2.3. Background information
- 16.2.4. Government Initiatives
- 16.2.5. Regulations
- 16.2.6. Regulatory bodies
- 16.2.7. Major Associations
- 16.2.8. Taxes levied
- 16.2.9. Corporate tax structure
- 16.2.10. Investments
- 16.2.11. Major Companies
- 16.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 16.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 16.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 16.6. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 17. Africa Market
- 17.1. Summary
- 17.2. Market Overview
- 17.2.1. Region Information
- 17.2.2. Market Information
- 17.2.3. Background Information
- 17.2.4. Government Initiatives
- 17.2.5. Regulations
- 17.2.6. Regulatory bodies
- 17.2.7. Major Associations
- 17.2.8. Taxes levied
- 17.2.9. Corporate tax structure
- 17.2.10. Investments
- 17.2.11. Major Companies
- 17.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 17.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 17.5. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 18. Competitive Landscape And Company Profiles
- 19. Company Profiles
- 19.1. FUJIFILM Holdings Corporation
- 19.1.1. Company Overview
- 19.1.2. Products And Services
- 19.1.3. Business Strategy
- 19.1.4. Financial Overview
- 19.2. Thermo Fisher Scientific, Inc
- 19.2.1. Company Overview
- 19.2.2. Products And Services
- 19.2.3. Business Strategy
- 19.2.4. Financial Overview
- 19.3. Takara Bio, Inc
- 19.3.1. Company Overview
- 19.3.2. Products And Services
- 19.3.3. Business Strategy
- 19.3.4. Financial Overview
- 19.4. Lonza Group AG
- 19.4.1. Company Overview
- 19.4.2. Products And Services
- 19.4.3. Business Strategy
- 19.4.4. Financial Overview
- 19.5. Astellas Pharma Inc
- 19.5.1. Company Overview
- 19.5.2. Products And Services
- 19.5.3. Business Strategy
- 19.5.4. Financial Overview
- 20. Key Mergers and Acquisitions
- 20.1. Vertex Pharmaceuticals Acquired ViaCyte
- 20.2. Medipost Acquired OmniaBio
- 20.3. Catalent Acquired RheinCell Therapeutics
- 20.4. Selvita Acquired Fidelta from Galapagos
- 20.5. Bayer Acquired Asklepios BioPharmaceutical (AskBio)
- 20.6. Boehringer Ingelheim Acquired Global Stem Cell Technology (GST)
- 20.7. Vertex Pharmaceuticals Acquired Semma Therapeutics
- 21. Opportunities And Strategies
- 21.1. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Countries Offering Most New Opportunities
- 21.2. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Segments Offering Most New Opportunities
- 21.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Growth Strategies
- 21.3.1. Market Trend Based Strategies
- 21.3.2. Competitor Strategies
- 22. Biotechnology Services Market, Conclusions And Recommendations
- 22.1. Conclusions
- 22.2. Recommendations
- 22.2.1. Product
- 22.2.2. Place
- 22.2.3. Price
- 22.2.4. Promotion
- 22.2.5. People
- 23. Appendix
- 23.1. Market Data Sources
- 23.2. Research Methodology
- 23.3. Currencies
- 23.4. The Business Research Company
- 23.5. Copyright and Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook